Dongkook Pharmaceutical, led by CEO Song Jun-ho, has introduced the ‘Expert Madeca Cream Core Voluming,’ a full-face volume lifting cream under its derma-cosmetic brand ‘Centellian24.’ This product is part of a promotional launch initiative.
The new cream was developed in collaboration with Taiwanese beauty influencer Marvis, known for her trendy yet expert beauty content and a strong global following. Marvis participated extensively in the development process, contributing to ingredient formulation and texture design, and ensuring the product delivers effective lifting effects and optimal user experience through multiple rounds of precise pre-launch testing.
The ‘Expert Madeca Cream Core Voluming’ is designed to simultaneously address volume loss in specific areas, sagging skin, and deep wrinkles. It targets the ‘Five Key Youth Spots’—forehead, under-eye regions, core midface, nasolabial folds, and lateral cheeks—while offering tightening care for sagging double chin lines and pore entrances, effectively enhancing the facial structure.
The formulation includes a 5% concentration of Volufiline™, an internationally patented ingredient developed by French ingredient supplier Sederma, known for its volume-enhancing properties. Additionally, it features Dongkook Pharmaceutical's core ingredient TECA (Titrated Extract of Centella Asiatica), 30 types of peptides, and ‘TECA-PEP™’, which is a proprietary blend.
Moreover, the cream incorporates four types of retinoids—retinol, retinal, HPR, and retinyl palmitate—along with NAD+ (Nicotinamide Adenine Dinucleotide) to help manage visible deep wrinkles around the nasolabial folds, eyes, and forehead effectively.
A representative of Centellian24 stated that this product exemplifies the synergy between influencer Marvis's discerning aesthetic and Dongkook Pharmaceutical's dermatological expertise. They encouraged consumers to experience the premium volume lifting care that ‘Expert Madeca Cream Core Voluming’ offers, aimed at achieving more resilient and contoured youthful skin.
